MoneyWorks4Me

Beryl Drugs - Quaterly Results

09 Aug 2024 Evaluate
The sales declined to Rs. 62.87 millions for the June 2024 quarter as compared to Rs. 81.71 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 3.68 millions from Rs. 5.32 millions, a decline of -30.83% on QoQ basis.Operating Profit reported a sharp decline to 9.86 millions from 11.34 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 62.87 81.71 -23.06 62.87 81.71 -23.06 271.25 271.40 -0.06
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 9.86 11.34 -13.05 9.86 11.34 -13.05 26.74 22.35 19.64
Interest 2.08 1.20 73.33 2.08 1.20 73.33 4.64 4.36 6.42
PBDT 7.78 10.14 -23.27 7.78 10.14 -23.27 22.10 17.99 22.85
Depreciation 2.82 2.82 0.00 2.82 2.82 0.00 12.01 8.14 47.54
PBT 4.96 7.32 -32.24 4.96 7.32 -32.24 10.09 9.85 2.44
TAX 1.28 2.00 -36.00 1.28 2.00 -36.00 2.41 2.18 10.55
Deferred Tax -0.10 -0.44 -77.27 -0.10 -0.44 -77.27 -1.98 0.58 -441.38
PAT 3.68 5.32 -30.83 3.68 5.32 -30.83 7.68 7.67 0.13
Equity 50.72 50.72 0.00 50.72 50.72 0.00 50.72 50.72 0.00
PBIDTM(%) 15.68 13.88 13.01 15.68 13.88 13.00 9.86 8.24 19.71
Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1212.30
Cipla 1368.65
Lupin 2121.05
Zydus Lifesciences 1170.00
View more..